My Cart [ 0 ]
Proteins & Peptides
New Products
New Services
Promotions
News
Home > Proteins & Peptides
Natural and recombinant proteins purified from bacteria (such as E. coli, B. subtilis), yeast (such as S. cerevisiae), baculovirus/insect, mammalian cells (such as CHO cell lines), and cell-free systems.
    4065 Proteins & Peptides Products
  • BP000036-GD10: Recombinant Human FVII Protein

    Source: HEK 293 cell derived.
    Endotoxin Level: <1.0 EU per 1 ug of the protein by the LAL method.
    Purity > 95%, by SDS-PAGE under reducing conditions and visualized by silver stain.

  • BP000036-GD11: Recombinant Human FVIIa Protein

    Source: 293 cell derived.
    The potency per mg of recombinant human FVIIa protein was tested and found to be 50,000 Units/mg.
    Endotoxin Level: <1.0 EU per 1 ug of the protein by the LAL method.
    Purity > 95%, by SDS-PAGE under reducing conditions.

  • BP000037-GD12: Recombinant Human FVIII Protein

    Source: 293 cell-derived
    The potency per mg of recombinant human FVIII protein was tested and found to be 11,000 Units/mg.
    Endotoxin Level: <1.0 EU per 1 ug of the protein by the LAL method.
    Purity > 95%, by SDS-PAGE under reducing conditions and visualized by silver stain.

  • BP000051-GD14: Recombinant Human OPG-Fc Fusion Protein

    Source: HEK 293-derived.
    The Osteoprotegerin / OPG / TNFRSF11B / OCIF / OBF activity is calculated by its ability to inhibit TRAIL-mediated cytotoxicity using L929 mouse fibrosarcoma cells treated with TRAIL. The ED50 for this effect is typically 5 ng/ml.
    Endotoxin: < 5.0 EU per 1 ug of the protein by the LAL method.
    Purity: > 90% by SDS-PAGE and RP-HPLC.

  • BP000339-GD15: Recombinant Human Chorionic Gonadotropin (hCG)

    Source: CHO-derived.
    The hCG α/β activity was determined to be 25,000 IU/mg.
    Purity > 97% by SDS-PAGE under reducing conditions and visualized by silver stain, and 97% by SEC-HPLC.

  • BP002388-Z53: Recombinant Human Cellular tumor antigen p53 (p53) Protein

    Source: Baculovirus, SF9 insect cells-derived.
    Bioactivity test: 1 unit equals 1 nanogram of purified protein. 10 unit is sufficient for a gel mobility shift assay in a 20 ul reaction; 50 units are sufficient for reconstituted transcription assay and 100 units are sufficient for a protein-protein interaction assay.
    Purity: > 95%, by SDS-PAGE.
    Endotoxin Level: < 1.0 EU per 1 ug of the protein by the LAL method.

  • BP000027-GD1: Recombinant Human VEGF165 (aa 27-191) Protein

    Source: HEK 293 cell-derived.
    The VEGF activity is measured in a cell proliferation assay using human umbilical vein endothelial cells (HUVEC). The ED50 for this effect is typically 1-5 ng/ml.
    Endotoxin: < 1.0 EU per ug of the protein by the LAL method.
    Purity: > 95% by SDS-PAGE under reducing conditions.

  • BP000035-GD9: Recombinant Human FSH α/β Protein

    Source: CHO cell-derived.
    The FSH α/β activity is measured in a human FSH receptor transfected HEK 293 cells. The ED50 for this effect is 0.1-0.4 ng/ml.
    Endotoxin Level: <1.0 EU per 1 ug of the protein by the LAL method.
    Purity > 95%, by SDS-PAGE under reducing conditions and visualized by silver stain.

  • BP000050-GD13: Recombinant Human RANKL Protein

    Source:E. coli-derived.
    The RANKL / TNFSF11 / TRANCE / OPGL / CD254 activity is calculated by its ability to induce osteoclast differentiation on RAW 264.7 mouse macrophages. The ED50 for this effect is 2-12 ng/ml.
    Endotoxin Level: <1.0 EU per ug of the protein by the LAL method.
    Purity > 95%, by SDS-PAGE and SEC-HPLC.

  • BP001573-K0104: Recombinant Human PAK1 Kinase Domain (PAK1KD) Enzyme

    Source: E. coli-derived.
    Specific activity: 32,638 pmoles/min/ug. Analysis of enzymatic activity was performed according to the Zlyte assay protocol (Invitrogen).
    Applications: Enzymatic studies, inhibitor screen, and selectivity profiling; High concentration available for crystallization.

Proteins & Peptides Categories

See our Privacy Policy